Insiders BioSenic SA

Equities

Real-time Euronext Bruxelles Other stock markets 03:36:11 10/05/2024 pm IST			5-day change	1st Jan Change
0.014 ^EUR	+3.70%		+2.19%	-77.12%

11/04	Biosenic: launch of a debt restructuring plan	CF
12/03	Biosenic S.A. Releases Details of Optimized Administration Approach Ahead of Planned Phase 3 Trial of OATO for Chronic Graft-Versus-Host Disease	CI

BioSenic Names Chief Scientific Officer as COO	10/01	MT
Biosenic S.A. and Its Subsidiary Medsenic SAS Announces the Promotion of Carole Nicco to Chief Operating Officer	10/01	CI
Belgium's BioSenic Appoints New Chief Medical Officer	03/23/03	MT
BioSenic S.A. Appoints Lieven Huysse as Chief Medical Officer, Effective 17 April 2023	03/23/03	CI
BioSenic S.A. Appoints Yves Sagot as Independent Director	27/23/27	CI
BioSenic Names New Chief Scientific Officer	18/23/18	MT
BioSenic Appoints Dr. Carole Nicco as Chief Scientific Officer	18/23/18	CI
BioSenic Names Interim Chief Medical Officer	02/22/02	MT
BioSenic S.A. Appoints Michel Wurm as Interim Chief Medical Officer	02/22/02	CI
Bone Therapeutics To Change Name To BioSenic Following Medsenic Deal	25/22/25	MT
Francois Rieger Joins as CEO of BioSenic SA	25/22/25	CI
BioSenic Announces Management Changes	25/22/25	CI
Bone Therapeutics SA has Changed its Name to BioSenic SA	25/22/25	CI
Bone Therapeutics CEO, Other Executives to Leave Amid Revised Strategy; Shares Down 9%	29/22/29	MT
Bone Therapeutics Appoints Scientific Advisory Board for iMSC Cell and Gene Therapy Platform Development	12/21/12	CI
Hyloris Pharmaceuticals : Appoints New CFO From Bone Therapeutics	23/21/23	MT
Bone Therapeutics : Hires Interim CFO	21/21/21	MT
Bone Therapeutics SA Announces Executive Changes	21/21/21	CI
Bone Therapeutics Appoints Anne Leselbaum, MD as Chief Medical Officer, Effective 23 August 2021	12/21/12	CI
Bone Therapeutics Appoints Anthony Ting as Chief Scientific Officer	30/21/30	CI

No results for this search